Thrombocytopenia: all 703 studies

Page 4 of 8. Open to participants first (151), then studies with results posted, then the rest; newest registration first within each.

• Bleeding Events Before vs After Lowering Departmental Platelet Transfusion TriggerCompletedNCT06187831
• The Safety and Tolerability of STSA-1301 Subcutaneous Injection in Healthy SubjectsCompletedNCT06148389Phase 1
• Clinical Performance Evaluation of T-TAS®01 HD ChipCompletedNCT06087198
• Andalusian Experience in the Use of Fostamatinib in Patients With ITP. FOSTASUR StudyCompletedNCT06071520
• PRedicting OutcomeS in Preterm nEonates With thromboCyTopeniaCompletedNCT06043050
• The Effect of Prophylactic TPO Combined with BMS-IMRT to Esophageal Cancer PatientsCompletedNCT05944809Phase 2
• Efficacy of Intravenous N-Acetylcysteine in Preventing Linezolid-Induced Thrombocytopenia in Critically Ill PatientsCompletedNCT05944458Phase 4
• Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Solid Tumors.Active, not recruitingNCT05864014Phase 3
• Evaluating the Efficacy and Safety of QL0911 in Chemotherapy- Induced ThrombocytopeniaCompletedNCT05851027Phase 2/3
• A Phase 2 Study of VLX-1005 Versus Placebo in Suspected Heparin Induced ThrombocytopeniaTerminatedNCT05785819Phase 2
• Comparison of Pre-test Probability Model for Heparin-induced Thrombocytopenia in Post-operative Cardiac SurgeryStatus unknownNCT05783895
• Human Mass Balance of [14C]HMPL-523 in Healthy Adult Male Chinese SubjectsCompletedNCT05781906Phase 1
• A Prospective, One-arm and Open Clinical Study of CM313 in the Treatment of Immune ThrombocytopeniaCompletedNCT05694767Phase 2
• Tacrolimus Plus Glucocorticoid for Severe Thrombocytopenia in SSStatus unknownNCT05694130Phase 2/3
• To Evaluate Thrombosis Risk in Chemotherapy Patients With Solid Tumors Who Receiving Thrombocytopenia TreatmentCompletedNCT05688306
• Extension Study of Herombopag for Pediatric Patients With Chronic Immune ThrombocytopeniaStatus unknownNCT05685420Phase 3
• Tacrolimus for Thrombocytopenia in SSStatus unknownNCT05678335Phase 2/3
• Umbilical Cord Derived Mesenchymal Stem Cells for Treatment-induced Myelosuppression in Hematologic MalignanciesStatus unknownNCT05672420Phase 1/2
• Assesment of the Functional Activity of Platelets for the Differential Diagnosis of ThrombocytopathiesStatus unknownNCT05654766
• IVIg Plus Low Dose rhTPO for ITP in PregnancyStatus unknownNCT05634824Phase 2
• Clinical Decision Support for Blood Transfusions to Improve Guideline AdherenceCompletedNCT05634005Not applicable
• Efficacy and Safety of QL0911 in Adult Patients With Chronic Primary Immune ThrombocytopeniaCompletedNCT05621330Phase 3
• Real World Evaluation of the Activity and Safety of Fostamatinib in Consecutive Adult Patients With ITPCompletedNCT05613296
• Multicenter Study on Dialysis Modalities for End-stage Chronic Renal Failure Patients With Heparin-induced ThrombocytopeniaStatus unknownNCT05586854Not applicable
• Safety of Acupuncture and Intracutaneous Needles in Pediatric Cancer Patients: a Retrospective Study (ACUSAFE2021)CompletedNCT05585463
• A Randomized Trial Comparing Optimized rhTPO Treatment With Eltrombopag Treatment in Pre-treated ITP PtsCompletedNCT05583838Phase 4
• Herombopag Olamine in the Treatment of Thrombocytopenia After ChemotherapyStatus unknownNCT05575986Phase 4
• Effect of Herbal Formulation on Thrombocytes CountStatus unknownNCT05563064Phase 3
• A Clinical Trial to Assess Safety and Efficacy of Daratumumab in the Treatment of Primary Immune ThrombocytopeniaActive, not recruitingNCT05562882Phase 2
• Evaluating the Efficacy and Safety of QL0911 in the Prevention of Chemotherapy- Induced ThrombocytopeniaCompletedNCT05554913Phase 2/3
• Evaluation of the Effect in Platelet Count of Atorvastatin and N-acetyl CysteineCompletedNCT05551624Early Phase 1
• The Combination of Terbutaline and Danazol as the Treatment of Corticosteroid-resistant/Relapse Immune ThrombocytopeniaStatus unknownNCT05494307Phase 2
• The Combination of Tacrolimus and Danazol as the Treatment of Steroid-resistant/Relapse Immune ThrombocytopeniaStatus unknownNCT05471050Phase 2
• A Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in Participants With International Prognostic Scoring System Revised (IPSS-R) Low- or Intermediate-risk Myelodysplastic Syndrome (MDS)Active, not recruitingNCT05469737Phase 2/3
• The Expression of Immune Checkpoint CD28 rs1980422-related Single-nucleotide Polymorphisms in the Primary Immune ThrombocytopeniaStatus unknownNCT05468866Not applicable
• The Use of Eltrombopag Post HSCT in BMFDCompletedNCT05466201Phase 2/3
• Baricitinib for Steroid-resistant/Relapse Immune ThrombocytopeniaStatus unknownNCT05446831Phase 2
• EMR Tool Impact on HIT Documentation and ManagementCompletedNCT05439265
• A Multicenter Randomized Open-label Study of Chidamide Plus HD-DEX Versus HD-DEX in ITPStatus unknownNCT05411874Phase 2
• Assessment of FOXP3 Gene Polymorphisms and Serum Interleukin 10 in Patients With ITPStatus unknownNCT05410249
• Venous Thromboembolism in Hematologic Malignancy and Hematopoietic Cell Transplant Patients: a Retrospective StudyActive, not recruitingNCT05396157
• SABRE: A Single-arm Prospective Study Measuring Safety and Tolerability of SARS-CoV-2 Neutralising Antibodies in High-risk PopulationsWithdrawnNCT05393999Phase 2
• Hetrombopag for Lower-risk MDS With Thrombocytopenia: a Prospective，Open-label, Single-arm Study.Status unknownNCT05392647Phase 2
• Efficacy and Safety of Avatrombopag for Treating TCP in HBV-ACLF Patients Receiving ALSS TreatmentStatus unknownNCT05382013Phase 4
• Plasma microRNA Levels and Some Cytokines Expression in Patients With ITP Primary Immune Thrombocytopenic Purpura (ITP)Status unknownNCT05371743
• Platelet Augmentation Using C. Papaya Leaf Extract in Live Donor Liver TransplantationStatus unknownNCT05360134Not applicable
• The Combination of Sitagliptin and Danazol as the Treatment of Steroid-resistant/Relapse Immune ThrombocytopeniaStatus unknownNCT05353673Phase 2
• A Clinical Study of Herombopag in Tumors-associated ThrombocytopeniaStatus unknownNCT05350956Phase 2
• The Combination of Prednisone and Recombinant Human Thrombopoietin for Treatment of Immune Thrombocytopenia in PregnancyStatus unknownNCT05333744Phase 2
• Herombopag + rhTPO in Severe Immune ThrombocytopeniaStatus unknownNCT05328804Phase 3
• Romiplostim Plus Dexamethasone vs Dexamethasone in Patients With Newly Diagnosed Primary Immune ThrombocytopeniaActive, not recruitingNCT05325593Phase 3
• A Phase I Study of the Co-administration of VLX-1005 and Argatroban in Healthy Human SubjectsCompletedNCT05325346Phase 1
• Efficacy and Safety of TPO Receptor Agonists in the Treatment of Elderly ITP PatientsStatus unknownNCT05311930Phase 4
• Efficacy and Safety of Iguratimod in the Treatment of Steroid-resistant/Relapse Immune ThrombocytopeniaStatus unknownNCT05302024Phase 2
• The Combination of Iguratimod and Danazol as the Treatment of Steroid-resistant/Relapse Immune ThrombocytopeniaStatus unknownNCT05281068Phase 2
• A Study of Zanubrutinib in Patients With ITPCompletedNCT05279872Phase 2
• A Clinical Study of Hetrombopag Olamine Tablets in Adults Receiving 21-day Cycles of Chemotherapy for Solid Tumours, Who Are Delayed for at Least 1 Week From Their Scheduled Cycle Because of Chemotherapy-induced ThrombocytopeniaWithdrawnNCT05261646Phase 3
• Association of the Risk for Thrombotic Thrombocytopenia Syndrome and Exposure To COVID-19 VaccinesCompletedNCT05252442
• An Exploratory Study of Herombopag for Thrombocytopenia Induced by Chemotherapy Combined With Immunotherapy in NSCLCStatus unknownNCT05252091Phase 2
• A Study to Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Immune ThrombocytopeniaStatus unknownNCT05232149Phase 2
• HIV Indicator Diseases in Hospital and Primary CareStatus unknownNCT05225493
• Epidemiology of Thrombotic Thrombocytopenia Syndrome in Integrated Health-care Database in EnglandCompletedNCT05222750
• Effects of Recombinant Human Thrombopoietin on Platelet Levels in ICU PatientsStatus unknownNCT05217719Phase 4
• A Phase Ib Clinical Study for rhTPO in the Treatment of Thrombocytopenia in Patients With Chronic Liver DiseaseStatus unknownNCT05193201Phase 1
• Clinical Study on the Efficacy and Safety of Hetropapa Ethanolamine Tablets in the Treatment of Thrombocytopenia Caused by Concurrent Radiotherapy and Chemotherapy in Cervical CancerStatus unknownNCT05160857Not applicable
• A Real-world Study of Herombopag in the Treatment of Thrombocytopenia Related Diseases in Henan ProvinceStatus unknownNCT05130424
• A Study of Orelabrutinib in Patients With ITPStatus unknownNCT05124028Phase 1/2
• Machine-learning Based Prediction Model in Primary Immune ThrombocytopeniaStatus unknownNCT05116423
• The Serum Lipid Profiles in ITP: a Retrospective StudyCompletedNCT05095896
• National Vaccine Adverse Event Reporting Survey and EtiologyStatus unknownNCT05095844
• Administration of Fibrinogen Concentrate for Refractory BleedingTerminatedNCT05091684Phase 2
• Treatment of Avatrombopag for Thrombocytopenia in Patients Undergoing Selective Resection of Hepatocellular CarcinomaStatus unknownNCT05087459
• Study on the Safety and Efficacy of Cryopreserved Platelets in Hypoproliferative Thrombocytopenic PatientsCompletedNCT05067608Phase 1/2
• Understanding the Risk of Blood Clots and Bleeding in Patients With Hematological Malignancies, HAT StudyCompletedNCT05053100
• Open-Label Study to Evaluate the Safety and Efficacy of Avatrombopag and Remission Rates in Adults With ITP of ≤6 MonthsWithdrawnNCT05046327Phase 3
• COVID-19 ThromboprophylaXIs Study of Novel FXIa Inhibitor Frunexian (EP-7041) in ICU PatientsWithdrawnNCT05040776Phase 2
• Hetrombopag for Low/Intermediate-1 Risk MDS With ThrombocytopeniaStatus unknownNCT05024877Phase 2/3
• A Clinical Trial of the Orelabrutinib in the Management of Refractory ITPStatus unknownNCT05020288Phase 2
• Avatrombopag in the Treatment of Primary Immune Thrombocytopenia(ITP)Status unknownNCT04949009
• Phase II Trial of Romiplostim for Thrombocytopenia Induced by Lomustine at First Progression of MGMT Promoter-meth GlioblastomaWithdrawnNCT04933942Phase 2
• Study of Avatrombopag for Temozolomide-induced Thrombocytopenia in Glioma (APATIT-G)WithdrawnNCT04931849Early Phase 1
• Eltrombopag Plus Diacerein vs Eltrombopag in Adult ITPCompletedNCT04917679Phase 2
• Efficacy of Avatrombopag in Thrombocytopenic Patients With Chronic Liver Disease Undergoing an Elective ProcedureStatus unknownNCT04915287Phase 4
• Avatrombopag in Patients With End-stage Liver Disease and ThrombocytopeniaStatus unknownNCT04906083Phase 4
• Observational Study of Fostamatinib as Second Line Therapy in Adult Patients With Immune Thrombocytopenia (ITP) and Insufficient Response to a Prior TherapyTerminatedNCT04904276
• Efficacy and Safety of Avatrombopag in Cancer Patients With ThrombocytopeniaStatus unknownNCT04896528Phase 2
• Collection of the Thrombo-VaxCov CohortWithdrawnNCT04889326
• Avatrombopaq In Patients With CirrhosisStatus unknownNCT04845659Phase 4
• Study on the Relationship Between Neutrophil-mediated Thrombocytopenia and the Condition and the Course of Disease in Patients With HFRSStatus unknownNCT04834713
• Immunomodulation With Eltrombopag in ITPCompletedNCT04812483Phase 2
• Avatrombopag for the Primary Prevention of Thrombocytopenia Induced by Cytarabine-based Chemotherapy in Patients With LymphomaStatus unknownNCT04797182Phase 2
• Evaluation of the Intra-observer Agreement of the HEP Score in Surgical Intensive Care.Status unknownNCT04782843
• Argatroban Monitoring in Critically Ill Patients: Evaluation of a Novel Ecarin-based Bedside TestStatus unknownNCT04751357
• The Combination of Tacrolimus and High-dose Dexamethasone as First-line Treatment in Adult Immune ThrombocytopeniaStatus unknownNCT04747080Phase 2
• Post IVIG Medication in Children With Immune ThrombocytopeniaStatus unknownNCT04741139Phase 1
• Investigation on the Incidence and Course of COVID-19 in Patients With Prior, Ongoing or de Novo ITP. Evaluation of the Impact of COVID-19 Pandemic on the Management of ITPStatus unknownNCT04735588
• Using Romiplostim to Treat Low Platelet Counts During Chemotherapy in People With LymphomaCompletedNCT04673266Phase 2
• Thrombosomes® in Bleeding Thrombocytopenic Patients StudyTerminatedNCT04631211Phase 2
• A Study of ATRA in the Treatment of ITPStatus unknownNCT04618328Phase 2
• Avatrombopag on the Treatment of Thrombocytopenia Induced by Chemotherapy of Malignant TumorsCompletedNCT04609891Not applicable

← Thrombocytopenia overview